Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07725640) titled 'Feasibility Assessment of a Medical Device for Tumour Cell Retention and Radiotherapy Sensitization in Patients With Suspected High-grade Glioma' on July 21.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: Batea Oncology
Condition:
Glioma
High-Grade Glioma (HGG)
Surgical Resection
Intervention:
Device: GlioHook device
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 30, 2026
Target Sample Size: 15
Countries of Recruitment:
Spain
To know more, visit h...